Research on the SARS-CoV-2 virus itself. Covers antiviral trials, antibody neutralization, viral escape, and rapid detection methods.
Researchers have discovered that seemingly 'broken' genes in coronaviruses are retained due to their functional role beyond protein production. These extra genes help control the activity of other viral genes.
The Association for Molecular Pathology has published a joint consensus report on SARS-CoV-2 genomic surveillance, outlining key considerations for next-generation sequencing methods. The report provides guidance on pre-analytical, analytical, and post-analytical aspects of NGS-based surveillance programs.
Researchers discover SARS-CoV-2 hijacks three host proteins to shield itself from complement-mediated lysis, significantly impairing viral clearance. This may affect the course of acute and post-COVID-19 sequelae, deepening our understanding of immune evasion mechanisms.
Research highlights correlation between preeclampsia and COVID-19 in pregnant women, identifying biomarkers for differential diagnosis. The review article emphasizes the pathophysiological similarities between the two conditions, including shared pathways involving the renin-angiotensin system and ACE2.
A longitudinal cohort study found no significant associations between prenatal SARS-CoV-2 infection and child neurodevelopment outcomes in the first two years of life. Follow-up research is needed to determine if these effects persist into later childhood.
Researchers from the IBB-UAB have developed novel nanoparticles capable of trapping and neutralizing large quantities of SARS-CoV2 virus particles. These nanostructures could be used to manufacture antiviral materials such as wastewater and air filters, and develop new tests for early Covid-19 detection.
Researchers at Kumamoto University have developed a cutting-edge diagnostic tool, Intelli-OVI, to rapidly identify emerging SARS-CoV-2 variants. This system combines advanced DNA detection technology with computational algorithms to offer a quicker and more cost-effective method of monitoring viral mutations.
Researchers developed a new surveillance technique to track COVID-19 diversity using genomic data, predicting variant emergence with high accuracy. The software can forewarn public health officials of impending outbreaks, enabling timely responses and more effective disease monitoring.
Elevated body mass index (BMI) was associated with a significantly increased post-acute sequelae of SARS-CoV-2 infection risk. The study highlights the need for targeted care to prevent chronic conditions in at-risk children and young adults.
The novel coronavirus SARS-CoV-2 has an enzyme that counteracts the innate defense mechanism against viruses, allowing it to evade the innate immune system and become more infectious. Understanding this mechanism may lead to the development of new antiviral drugs and treatments.
A phase Ib clinical trial has shown that the MVA-MERS-S vaccine candidate is safe and effective in healthy individuals previously infected with SARS-CoV-2. The vaccine was tested in a placebo-controlled study with no serious vaccine-related side effects, indicating promising results.
A new study reveals that mild and asymptomatic SARS-CoV-2 infections can trigger immune responses in pregnant individuals, causing serious inflammatory responses in the developing fetus. The study also found that even without full infection, a pregnant individual's immunological response to infection may impact the fetus.
A retrospective cohort study of children and adolescents found a higher risk of developing type 2 diabetes after COVID-19 infection compared to other respiratory infections. The study suggests potential long-term effects on glucose regulation.
Researchers at Brigham and Women's Hospital found that people with wide-ranging long COVID symptoms were twice as likely to have SARS-CoV-2 proteins in their blood compared to those without long COVID symptoms. This persistent infection could explain some of the long COVID sufferers' symptoms, suggesting a potential treatment target.
Researchers at the University of São Paulo developed a synthetic peptide that mimics the ACE2 receptor, blocking SARS-CoV-2 invasion and reducing inflammation in human lung cells and mice. The peptide could be customized for every variant, offering a fast-acting molecular shield against the virus.
Researchers developed a modular click chemistry method to synthesize catechol derivatives, which showed potent inhibitory effects against SARS-CoV-2 3CL pro with low cytotoxicity. The study demonstrates the feasibility of this approach for natural-product-based structural modifications in antiviral drug discovery.
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
A new method combines confocal fluorescence microscopy with microfluidic laminar flow to detect nanoparticles and viruses quickly and accurately. The approach uses a 3D-printed Brick-MIC setup for sensitivity and specificity improvements, potentially changing virus detection in clinical settings.
Researchers have identified a novel small-molecule inhibitor of SARS-CoV-2 using chemical genetics. The compound, designated 172, demonstrates broad-spectrum antiviral activity against multiple human pathogenic coronaviruses and different SARS-CoV-2 variants of concern.
Treatment-emergent nirmatrelvir resistance mutations were commonly detected in immunosuppressed individuals, but at low frequencies and transient nature. The study suggests a low risk for the spread of nirmatrelvir resistance in the community with current variants and drug usage patterns.
The study reveals how SARS-CoV-2 ORF10 exploits the ubiquitination pathway by mimicking Gly/N-degrons to bind CUL2 ZYG11B, leading to degradation of IFT46 and dysfunctional cilia. This mechanism offers a promising target for developing PROTAC-based drugs to combat COVID-19.
Long COVID patients face numerous barriers and frustrations in receiving care, yet express a desire for collaborative treatment planning. The study highlights the need for improved communication and collaboration between patients and healthcare professionals.
A recent cohort study found that prenatal exposure to COVID-19 during pregnancy did not increase the risk of autism screening in toddlers. The research suggests that maternal SARS-CoV-2 infection and pandemic-related exposure had no significant impact on autism positivity rates.
A new study provides further evidence that SARS-CoV-2, the virus responsible for COVID-19, likely originated from animals sold at the Huanan Seafood Market in Wuhan, China. The analysis of genetic data found that wildlife species such as raccoon dogs and civet cats were present at the market and may have carried the virus.
A new international study provides a list of wildlife species present at the Huanan Seafood Wholesale market where SARS-CoV-2 likely arose. Genetic material from raccoon dogs, civet cats, and other species was found in samples from market stalls.
Researchers isolated drug-resistant strains of SARS-CoV-2 from immunocompromised individuals who received antiviral treatments. The virus variants showed resistance to Paxlovid and remdesivir, highlighting the need for combination therapy to treat COVID-19 in highly vulnerable patients.
A new long-term study found that memory T cells can be established and maintain key features to fight off subsequent infections of newer strains, providing potential insight into rapid recovery from COVID. The study's findings are important for understanding how the body responds to COVID-19.
Researchers identified an antibody that assists some variants of the virus in infecting cells while blocking others, a dual-role effect. The study highlights the complexity of developing treatments as viruses evolve, but notes this phenomenon has not been observed in humans.
Researchers developed artificial lymphoid organ-chips to recreate human immune system's response to booster vaccines. The technology could potentially be used to evaluate the likely effectiveness of new protein and mRNA-based booster vaccines for COVID-19 and other infectious diseases.
Researchers developed a monoclonal antibody called SC27 that targets multiple parts of the SARS-CoV-2 spike protein, including conserved sections. The antibody shows promise against various COVID-19 variants and related coronaviruses, potentially benefiting immunocompromised patients
A study published in Nature found that immune cells called CD8+ T cells prevent lung healing and repair post-infection, leading to pulmonary fibrosis. This discovery may lead to new therapeutic treatment options for patients with long COVID.
This study found modestly increased risks of inflammatory bowel disease and bullous skin disorders in hospitalized patients infected with the Omicron variant. Booster vaccination mitigated long-term autoimmune sequelae risk.
A recent study by University of Missouri researchers found that giving nurses massages during their shifts can reduce physical aches and pains while improving mental rejuvenation. The study's lead researcher aims to create a healthier work environment where nurses are excited to remain in the profession long-term.
A recent study analyzing electronic medical records found obese individuals have a 34% increased odds of SARS-CoV-2 positivity. The research highlights obesity as a significant transmission risk factor for the virus among exposed individuals, regardless of age or sex.
Patients with post-COVID-19 mRNA vaccination myocarditis show lower cardiovascular complications at 18 months compared to those with conventional myocarditis. However, affected patients may require medical management for several months after hospital discharge.
Researchers found a specific deletion in the spike protein that enhances the virus' ability to infect brains of mice, which could help understand 'long COVID' and develop treatments. The study suggests viruses with this deletion can traffic from the lung to the brain, leading to neurological symptoms.
A cohort study found elevated depression and anxiety levels in unvaccinated people with COVID-19 diagnosis compared to before or without the virus. Vaccination was associated with lower incidence of mental illnesses after hospitalization for COVID-19.
Researchers developed a tool to identify high-risk children and adolescents with pediatric postacute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID. The study found that symptoms differed by age group, with some similarities but distinct patterns across childhood ages.
The study identified common symptoms for school-age children (headache, trouble sleeping) and adolescents (daytime tiredness/sleepiness, body pain), with 14 overlapping symptoms between the age groups. The research indexes provide a framework for studying long COVID in youth.
SARS-CoV-2 uses machinery of defense cells to induce expression of unproductive isoforms of key antiviral genes, disrupting normal protein production and immune response. The study provides fundamental information on potential targets for antiviral medications and immunomodulatory interventions.
Researchers at Rice University and Northeastern University have made a discovery in the fight against COVID-19, uncovering new insights into how the virus infects human cells and can be neutralized. They found that antibodies targeting a specific part of the spike protein can bind to it and prevent the virus from entering human cells.
A new study provides first-of-its-kind data on the pharmacokinetics and safety of intravenous remdesivir in treating SARS-CoV-2 coronavirus in pregnant women. The research reveals that no dose adjustments are necessary for remdesivir when used in pregnant women, with no safety concerns or adverse pregnancy outcomes identified.
A recent NIH-supported study found that standard lab tests may not effectively diagnose long COVID due to the lack of validated clinical biomarkers. Researchers suggest the development of novel laboratory-based tests to better understand the pathophysiology of the condition.
A national cohort study found that no routine clinical lab test can aid in diagnosing post-acute sequelae of SARS-CoV-2 infection. Ongoing inflammation is thought to contribute to symptoms like anosmia and PASC. Researchers also discovered a link between SARS-CoV-2 and diabetes risk, independent of PASC symptoms.
A new study found that routine laboratory tests are not reliable for diagnosing Long COVID, with no biomarker among 25 clinical laboratory values providing a clinically useful diagnosis. The researchers suggest treating symptoms rather than relying on lab results to diagnose the condition.
Scientists at St. Jude Children's Research Hospital found a link between a SARS-CoV-2 protein and the onset of multisystem inflammatory syndrome in children (MIS-C). A region of the SARS-CoV-2 nucleocapsid protein shares high sequence and immunogenic similarities to human protein SNX8, sparking an inflammatory response.
Researchers at the University of Houston have developed two nasal sprays, NanoSTING and NanoSTING-SN, to prevent respiratory virus transmission. NanoSTING is an immune activator that can protect against multiple viruses, while NanoSTING-SN is a pan-coronavirus vaccine that can prevent transmission to unvaccinated individuals.
Researchers at La Jolla Institute for Immunology have discovered immune cells, such as tissue resident memory cells, in the upper airway that can fight infections and build long-term immunity. These findings may lead to better vaccines and a deeper understanding of immunity against respiratory pathogens.
Researchers at WashU Medicine developed a nasal COVID-19 vaccine that halted transmission in hamsters, showing promise for controlling respiratory infections. The vaccine targeted the virus's entry points in the nose and mouth, reducing viral replication and preventing spread.
A new study from Yale University reveals that two bat coronaviruses, genetically similar to SARS-CoV-2, do not efficiently transmit between humans. The viruses were able to infect human respiratory tract cells and evade the body's defense systems but did not cause disease in hamsters or mice.
Researchers detected SARS-CoV-2 in six common backyard species, including deer mice, Virginia opossums, and raccoons, with unique viral mutations found in some animals. The study highlights the need for broad surveillance and suggests that areas with high human activity may serve as points of contact for cross-species transmission.
Researchers have analyzed the spike protein structures of newly emerged SARS-CoV-2 subvariants, revealing distinct '3-receptor-binding domains (RBDs)-up' and '2-RBDs-up, 1-RBD-down' states. The study supports the idea that immune escape is enhanced while receptor binding capacity fluctuates in evolving subvariants.
A new study led by UCLA found a 3% to 4% prevalence of ME/CFS-like illness among participants who tested positive for SARS-CoV-2 infection, similar to those who tested negative. The research suggests COVID-19 may not be the primary cause of ME/CFS.
The emergence of recombinant variants like Deltacron, XE, XD, and XF has led to enhanced transmissibility and immune evasion capabilities. These variants result from co-circulating Delta and Omicron strains, allowing coinfections and eventual recombination.
A recent study published in BMC Psychology found that mild COVID-19 patients experienced significant cognitive impairment, with 11.7% showing memory loss and attention deficits. The study suggests that neuroinflammation due to SARS-CoV-2 infection may be a contributing factor to these long-term effects.
Researchers have discovered that SARS-CoV-2 can infect more types of lung cells than previously thought, including those without known viral receptors. The study also found that the lung can independently muster an inflammatory antiviral response without immune system help when exposed to the virus.
Researchers at Ohio State University are exploring the role of caspase 11 in SARS-CoV-2 infection, aiming to prevent inflammation and tissue injury. They will use human cell samples and experimental inhibitors to develop new treatment strategies for long COVID.
A natural experiment-based study in Chile found a significant impact of the COVID-19 pandemic on maternal mortality from non-respiratory causes. The study revealed an increase in indirect obstetric causes, possibly linked to comorbidities such as diabetes and hypertension.
Researchers found that the recent SARS-CoV-2 variants BA.2.86 and JN.1 have only minor changes in immune evasion compared to their predecessor Omicron, contradicting initial public health concerns.
The study analyzed over 1.8 million SARS-CoV-2 genome sequences to track virus variant spread and evolution. The introduction of free rapid antigen tests, mask regulations, and movement restrictions led to a significant decline in new variants entering Germany.